Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Acknowledgement to Contributors33
Acknowledgement to Reviewers27
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy26
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration21
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer20
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival20
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer17
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review16
Research Progress on the Anticancer Activity of Plant Polysaccharides16
Patent Selections15
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer14
Protective Assessment of Novel (Bncs Formulation) against Brain Tumor14
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents14
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
0.058380126953125